NCT02760602 A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02759159 The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI Status UNKNOWN Phase NA
NCT02756858 An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02754830 A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD) Status COMPLETED Phase PHASE1
NCT02752750 Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease Status UNKNOWN Phase N/A
NCT02750982 Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases. Status COMPLETED Phase NA
NCT02742597 Patient-Centred Innovations for Persons With Multimorbidity - Ontario Status COMPLETED Phase NA
NCT02719327 Brain Amyloid and Vascular Effects of Eicosapentaenoic Acid Status COMPLETED Phase PHASE2/PHASE3
NCT02711683 DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil Status COMPLETED Phase N/A
NCT02710188 Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation Status COMPLETED Phase PHASE1
NCT02709356 Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease Status COMPLETED Phase NA
NCT02708485 Effect of Walking on Brain Fuel Consumption in Mild Alzheimer's Disease Status COMPLETED Phase NA
NCT02695004 Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil). Status COMPLETED Phase PHASE1
NCT02690896 Caregiver Burden and Depression: Caring for Those Who Care for Others Status COMPLETED Phase NA
NCT02686216 Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph ) Status COMPLETED Phase PHASE1